Insider Transactions Reported by 12 Insiders of CNS Pharmaceuticals, Inc.

Symbol
CNSP on Nasdaq
Location
Houston, TX

There are no Buy or Sell transactions made by insiders since 29 Jan 2025

CNS Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Waldemar Priebe 10%+ Owner $198,486 06 Dec 2022
Cortice Biosciences, Inc. 10%+ Owner $172,010 30 Jul 2024
Carl Anthony Evans Director $54,165 08 Apr 2024
Jerzy Gumulka Director 17 Nov 2025
Amy Mahery Director 17 Nov 2025
Jeffry R. Keyes Director 17 Nov 2025
Rami Levin CEO and President, Director 01 Jan 2026
Bettina M. Cockroft Director 17 Nov 2025
Christopher Downs Chief Financial Officer 17 Nov 2025
John M. Climaco Chief Executive Officer, Director 17 Nov 2025
Andrzej Andraczke Director 21 Sep 2023
Faith L. Charles Director 17 Nov 2025

Recent Insider Transactions by Companies or Individuals for CNS Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.